**5. Conclusion**

The future of patients with unresectable and advanced melanoma is looking brighter than a decade ago. Besides immunotherapy revolution, promising approaches are emerging. Currently combination therapy, based on targeted therapy and immune checkpoint inhibitors is commonly recommended for increasing treatment efficacy. However, many challenges remain, regarding the mechanisms of tumorigenesis, the impact of tumor microenvironment on the immunogenicity of melanoma.
